Safer injections following a new national medicine policy in the public sector, Burkina Faso 1995 - 2000

BMC Public Health

Volumn 5, Issue , 2005, Pages

  Logez, Sophie ^a   Hutin, Yvan ^a   Somda, Paul ^b   Thuault, Jérôme ^c   Holloway, Kathleen ^a  

^a WORLD HEALTH ORGANIZATION   (Switzerland)

^b MINISTÈRE DE LA SANTÉ   (Burkina Faso)

^c Ministry of Health ^*  (Niger)

Author keywords

[No Author keywords available]

Indexed keywords

BURKINA FASO; DEVICE; HEALTH CARE ACCESS; HEALTH CARE COST; HEALTH CARE FACILITY; HEALTH CARE POLICY; HUMAN; INJECTION; INTERVIEW; MANAGER; NEEDLE; OBSERVATION; PATIENT SAFETY; PRESCRIPTION; PUBLIC HEALTH; RETROSPECTIVE STUDY; REVIEW; SYRINGE; DISINFECTION; DISPOSABLE EQUIPMENT; INFECTION CONTROL; PHARMACY; PROCEDURES; PUBLIC HEALTH SERVICE; SAFETY; STANDARDS; STATISTICS AND NUMERICAL DATA; SUPPLY AND DISTRIBUTION;

ESSENTIAL DRUG;

BURKINA FASO; DISINFECTION; DISPOSABLE EQUIPMENT; DRUGS, ESSENTIAL; HEALTH FACILITIES; HEALTH POLICY; HUMANS; INFECTION CONTROL; INJECTIONS; NATIONAL HEALTH PROGRAMS; NEEDLES; PHARMACIES; PUBLIC HEALTH ADMINISTRATION; RETROSPECTIVE STUDIES; SAFETY MANAGEMENT; SYRINGES;

EID: 31544437163     PISSN: 14712458     EISSN: 14712458     Source Type: Journal    
DOI: 10.1186/1471-2458-5-136     Document Type: Review

References (24)

1. Hutin YJ, Hauri AM, Armstrong GL: Use of injections in health care setting worldwide, 2000: literature review and regional estimates. BMJ 2003, 327(7423):1075.
2. Hauri A, Armstrong G, Hutin Y: The global burden of disease attributable to contaminated injections given in health care settings. Int J STD and AIDS 2004, 15:7-16.
3. Logez S, Hutin Y, Holloway K, Gray R, Hogerzeil HV: Could the WHO model list of essential medicines do more for the safe and appropriate use of injections? J Clin Pharmacol 2004, 44(10):1106-13.
4. Dicko M, Oni A-Q, Ganivet S, Kone S, Pierre L, Jacquet B: Safety of immunization injections in Africa: not simply a problem of logistics. Bull World Health Organ 2000, 78(2):163-9.
5. WHO-UNICEF-UNFPA Joint statement on the use of auto-disable syringes in immunization services Geneva: World Health Organization, WHO document WHO/V&B/99.25; 1999.
6. Guiding principles to ensure injection device security 2003 [http:www.who.int/injection_safety/WHOGuidPrinciplesInjEquipFinal.pdf]. Geneva: World Health Organization, WHO document WHO/BCT/03.12
7. Fitzner J, Aguilera JF, Yameogo A, Duclos P, Hutin Y: Injection practices in Burkina Faso in 2000. Int J Qual Health Care 2004, 16(4):303-8.
8. The Bamako initiative. Lancet 1988, 2(8621):1177-8.
9. The Bamako initiative. Lancet 1989, 1(8630):162-3.
10. Krause G, Borchert M, Benzler J, Heinmuller R, Kaba I, Sawadogo M, Siho N, Diesfeld SJ: Rationality of drug prescriptions in rural health centres in Burkina Faso. Health Policy and Plan 1999, 14(3):294.
11. Aguilera JF: Pilot testing the injection safety assessment tool in Burkina Faso. In Annual Meeting report, Safe Injection Global Network Geneva: World Health Organization, WHO document WHO/BCT/DCT/01.01; 2001:26.
12. Tool for the assessment of injection safety 2001 [http://www.who.int/ injection_safety/toolbox/en/InjectionSafetyAssessmentTool.pdf]. Geneva: World Health Organization, Basics II, WHO document WHO/V&B/01.30
13. Dziekan G, Chisholm DH, Johns B, Rovira J, Hutin YJF: The cost effectiveness of policies for the safe and appropriate use of injection in health care settings. Bull World Health Organ 2003, 81(4):277-85.
14. Ridde V: Fees-for-services, cost recovery and equity in a district of Burkina Faso operating the Bamako Initiative. Bull World Health Organ 2003, 81(7):532-8.
15. Hogerzeil HV, Walker GJ, Sallami AO, Fernando G: Impact of an essential drugs programme on availability and rational use of drugs. Lancet 1989, 1(8630):41-2.
16. Sharps injuries among health care workers. In The World Health Report 2002: reducing risks, promoting healthy life Geneva: World Health Organization; 2002:74. box 4.4
17. Meda N, Sangare L, Lankoande S, Compaoré IP, Catraye J, Sanou PT, Van Dyck E, Cartoux M, Soudre RB: L'épidémie à VIH au Burkina Faso: situation actuelle et niveau des connaissances de la population sur le SIDA, 1994-1995. Rev Epidemiol Santé Publique 1998, 46(1):14-23.
18. Lagarde E, Congo Z, Meda N, Baya B, Yaro S, Sangli G, Traoré Y, Van Renthergem H, Carael M: Epidemiology of HIV infection in urban Burkina Faso. Int J STD and AIDS 2004, 15(6):395-402.
19. Indicators for Monitoring National Drug Policies 1999 [http://hinfo198.tempdomainname.com/gsdl2/collect/edmweb/pdf/whozip14e/ whozip14e.pdf]. Geneva: World Health Organization, WHO document WHO/EDM/PAR/99.3
20. Aide Memoire for a national strategy for the safe and appropriate use of injections 2000 [http://www.who.int/injection_safety/about/country/ en/AMENG.pdf]. Geneva: World Health Organization, WHO document Department of blood safety and clinical technology
21. Procuring injection equipment and safety boxes 2003 [http://www.who.int/ injection_safety/toolbox/docs/en/Procurement.pdf]. Geneva: World Health Organization, WHO document WHO/BCT/ 03.04
22. A guide for the quality assurance of single-use injection equipment 2003 [http://www.who.int/injection_safety/toolbox/docs/en/InjEquQualityGuiden.pdf]. Geneva: World Health Organization, WHO document WHO/BCT/03.02
23. Pre-qualification of single-use injection devices under the Performance, Quality, Safety (PQS) system: a guideline for manufacturers 2003 [http://www.who.int/vaccines access/vacman/pis/ PQS_Prequalification_injection_devices_manufacturers_guideFINAL.pdf]. Geneva: World Health Organization, June WHO document
24. Managing an injection safety policy 2003 [http://www.who.int/ injection_safety/toolbox/en/ManagingInjectionSafety.pdf]. Geneva: World Health Organization, WHO document WHO/BCT/03.01